显性肝性脑病的一级预防：是时候考虑它了吗？
Primary Prophylaxis of Overt Hepatic Encephalopathy: Is It Time to Consider It?
作者信息
Faccioli Jessica, Nardelli Silvia, Gioia Stefania, Riggio Oliviero, Ridola Lorenzo
机构信息
Department of Translational and Precision Medicine, Sapienza University of Rome, 00185 Rome, Italy.
出版信息
J Clin Med. 2023 Jun 7;12(12):3903. doi: 10.3390/jcm12123903.
Abstract
Hepatic encephalopathy (HE) represents one of the most frequent complications of liver cirrhosis and one of the most debilitating clinical manifestations of liver disease due to the accumulation of toxic substances in the blood and central nervous system [...].
摘要
肝性脑病（HE）是肝硬化最常见的并发症之一，也是由于血液和中枢神经系统中有毒物质的积累导致的肝病最使人衰弱的临床表现之一[...]。
相似文献
1
Primary Prophylaxis of Overt Hepatic Encephalopathy: Is It Time to Consider It?显性肝性脑病的一级预防：是时候考虑它了吗？
J Clin Med. 2023 Jun 7;12(12):3903. doi: 10.3390/jcm12123903.
2
Diagnosis and management of hepatic encephalopathy.肝性脑病的诊断与管理
Br J Nurs. 2018 Feb 7;27(Sup3):S7-S13. doi: 10.12968/bjon.2018.27.Sup3.S7.
3
Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.肝硬化患者显性肝性脑病的一级预防：乳果糖与无乳果糖的开放性标签随机对照试验。
J Gastroenterol Hepatol. 2012 Aug;27(8):1329-35. doi: 10.1111/j.1440-1746.2012.07186.x.
4
Complications of Cirrhosis in Primary Care: Recognition and Management of Hepatic Encephalopathy.原发性护理中肝硬化的并发症：肝性脑病的识别与管理。
Am J Med Sci. 2018 Sep;356(3):296-303. doi: 10.1016/j.amjms.2018.06.008. Epub 2018 Jun 19.
5
Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial.益生菌可预防肝硬化患者肝性脑病：一项随机对照试验。
Clin Gastroenterol Hepatol. 2014 Jun;12(6):1003-8.e1. doi: 10.1016/j.cgh.2013.11.006. Epub 2013 Nov 15.
6
A Model for Predicting Development of Overt Hepatic Encephalopathy in Patients With Cirrhosis.肝硬化患者显性肝性脑病发展预测模型。
Clin Gastroenterol Hepatol. 2015 Jul;13(7):1346-52. doi: 10.1016/j.cgh.2014.12.025. Epub 2015 Jan 5.
7
Update on management of patients with overt hepatic encephalopathy.显性肝性脑病患者管理的最新进展。
Hosp Pract (1995). 2013 Aug;41(3):48-59. doi: 10.3810/hp.2013.08.1068.
8
Muscle Alterations Are Associated With Minimal and Overt Hepatic Encephalopathy in Patients With Liver Cirrhosis.肌肉改变与肝硬化患者的轻微和显性肝性脑病相关。
Hepatology. 2019 Nov;70(5):1704-1713. doi: 10.1002/hep.30692. Epub 2019 Jun 28.
9
Primary Prophylaxis Patterns for Hepatic Encephalopathy in Patients with Liver Cirrhosis: What are the Current Prescribing Trends in Specialty Practice?肝硬化患者肝性脑病的一级预防模式：专科实践中的当前处方趋势是什么？
J Assoc Physicians India. 2021 Aug;69(8):11-12.
10
[Guidelines on the management of hepatic encephalopathy in cirrhosis].[肝硬化肝性脑病管理指南]
Zhonghua Nei Ke Za Zhi. 2018 Oct 1;57(10):705-718. doi: 10.3760/cma.j.issn.0578-1426.2018.10.004.
本文引用的文献
1
Albumin for cognitive impairment after TIPS: A road to be explored.经颈静脉肝内门体分流术后白蛋白用于治疗认知功能障碍：一条有待探索的道路。
J Hepatol. 2023 Mar;78(3):e96-e97. doi: 10.1016/j.jhep.2022.10.002. Epub 2022 Oct 8.
2
EASL Clinical Practice Guidelines on the management of hepatic encephalopathy.EASL 临床实践指南：肝性脑病管理。
J Hepatol. 2022 Sep;77(3):807-824. doi: 10.1016/j.jhep.2022.06.001. Epub 2022 Jun 17.
3
Long-Term Efficacy and Safety of Rifaximin in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study.利福昔明治疗日本肝性脑病患者的长期疗效和安全性：一项多中心回顾性研究
J Clin Med. 2022 Mar 12;11(6):1571. doi: 10.3390/jcm11061571.
4
Concurrent large spontaneous portosystemic shunt embolization for the prevention of overt hepatic encephalopathy after TIPS: A randomized controlled trial.经颈静脉肝内门体分流术（TIPS）后同期行大口径自发性门体分流栓塞术预防显性肝性脑病：一项随机对照试验。
Hepatology. 2022 Sep;76(3):676-688. doi: 10.1002/hep.32453. Epub 2022 Apr 15.
5
Effects of Albumin on Survival after a Hepatic Encephalopathy Episode: Randomized Double-Blind Trial and Meta-Analysis.白蛋白对肝性脑病发作后生存率的影响：随机双盲试验与荟萃分析
J Clin Med. 2021 Oct 23;10(21):4885. doi: 10.3390/jcm10214885.
6
The improvement in body composition including subcutaneous and visceral fat reduces ammonia and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.体成分（包括皮下和内脏脂肪）的改善可降低经颈静脉肝内门体分流术后的氨和肝性脑病。
Liver Int. 2021 Dec;41(12):2965-2973. doi: 10.1111/liv.15060. Epub 2021 Sep 28.
7
Role of lactulose for prophylaxis against hepatic encephalopathy in cirrhotic patients with upper gastrointestinal bleeding: A randomized trial.乳果糖在肝硬化合并上消化道出血患者预防肝性脑病中的作用：一项随机试验。
Indian J Gastroenterol. 2021 Dec;40(6):621-629. doi: 10.1007/s12664-021-01150-2. Epub 2021 Jun 15.
8
Determining Whether Low Protein Intake (<1.0 g/kg) Is a Risk Factor for Malnutrition in Patients with Cirrhosis.确定低蛋白摄入量（<1.0克/千克）是否为肝硬化患者营养不良的危险因素。
J Clin Med. 2021 May 17;10(10):2164. doi: 10.3390/jcm10102164.
9
The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt : A Randomized Controlled Trial.利福昔明在经颈静脉肝内门体分流术后预防显性肝性脑病中的应用：一项随机对照试验。
Ann Intern Med. 2021 May;174(5):633-640. doi: 10.7326/M20-0202. Epub 2021 Feb 2.
10
Gut Microbiota Modulation and Fecal Transplantation: An Overview on Innovative Strategies for Hepatic Encephalopathy Treatment.肠道微生物群调节与粪便移植：肝性脑病治疗创新策略概述
J Clin Med. 2021 Jan 18;10(2):330. doi: 10.3390/jcm10020330.
Zotero 插件